On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayApr 01, 2022 12:28 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Earnings Call, 2021 Year-End Results Release Date

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has said it will release its year-end 2021 financial report on Monday, May 2, 2022, after the market closes. The report will also include subsequent events and MD&A. In addition, company management will host a conference call on Tuesday, May 3, 2022, to discuss that report. During that call, Red White and Bloom CEO Brad Rogers will also provide an overview of operations and upcoming events; the call will also include a question-and-answer session with company management. Those interested in the call can…

Continue Reading

FridayApr 01, 2022 12:19 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Releases Q4, FY 2021 Financial Report, Operational Highlights

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, is reporting financial results for the fourth quarter and full year for the period ended Dec. 31, 2021. Report highlights include record revenue for the company, which totaled $26.3 million for the year; an increase of $17.8 million or 208.6% over the $8.5 million reported in 2020; a processing volume increase of nearly tenfold to an estimated $2 billion; and a key licensing partnership with Cross River, a respected technology-driven infrastructure provider designed to initiate banking as a service offering, which will allow the company to significantly expand its reach to…

Continue Reading

ThursdayMar 31, 2022 12:57 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Commencement of Kernel Flow(R) Feasibility Study, Marking Exciting Moment for Psychedelic Drug Development

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that the first visit has been conducted in a Cybin-sponsored feasibility study. The study will focus on evaluating Kernel’s quantitative neuroimaging technology, Flow, to measure ketamine’s psychedelic effects on cerebral cortex hemodynamics. “The commencement of the Kernel feasibility study marks a truly exciting moment, not only for Cybin and Kernel, but also for the entire field of psychedelic drug development. To this point, studies have had to rely on subjective patient reporting,” said Cybin CEO Doug Drysdale. “By deploying the innovative Flow technology,…

Continue Reading

ThursdayMar 31, 2022 12:37 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Eyes ‘Tip of the Iceberg’ Opportunity with Launch of Platinum Vape(TM) Live Resin in Michigan

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, together with its RWB Michigan LLC wholly owned subsidiary, today announced the debut of Platinum Vape(TM) (“PV”) Live Resin in Michigan. Previously available only in California and Oklahoma, PV Live Resin will soon be in the nearly 400 Michigan dispensaries that now carry Platinum products. “As promised, the Red White & Bloom team is introducing a steady stream of new products and consumption options to satisfy consumer demand in the rapidly growing Michigan cannabis market,” said Brad Rogers, Red White & Bloom chairman…

Continue Reading

ThursdayMar 31, 2022 12:01 pm

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Releases Q4, Full-Year Results

Lottery.com (NASDAQ: LTRY), a leading technology company that is transforming how, where and when the lottery is played, is reporting its fourth-quarter and full-year 2021 revenue for the period ending Dec. 31, 2021. Q4 revenue totaled $21.5 million, an increase of $18.2 million over the previous year, with full-year revenue of $68.5 million, an increase of $61 million over 2020 numbers. The company also reported full-year 2021 pro forma revenue of $70.5 million, including acquired interest in Mexican entities, with full-year 2021 net loss of $9.3 million and adjusted EBITDA of $31.1 million. Corporate highlights include the company’s successful completion…

Continue Reading

ThursdayMar 31, 2022 11:18 am

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Enters Agreement to Significantly Advance Technologies ‘Closer to the Clinic’

Silo Pharma (OTCQB: SILO) is a developmental stage biopharmaceutical company focused on the use of psychedelics as a therapeutic. Silo Pharma today announced its entry into an agreement with Frontage Laboratories, a contract research organization (“CRO”) providing integrated, science-driven, product development services throughout the drug discovery and development process that enable life science companies to achieve their drug development goals. “This agreement significantly advances our Central Nervous System Peptide, SPU-16, and our Joint Homing Peptide, SPU-21 technologies closer to the clinic,” said Eric Weisblum, CEO of Silo Pharma. “These solutions have the potential to enhance the therapeutic effect of current…

Continue Reading

ThursdayMar 31, 2022 11:09 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces New Clinic Openings as Company’s Expansion Accelerates

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is opening Ketamine Wellness Centers (“KWC”) in Salt Lake City and Reno, Nevada, with additional locations planned to open this year. The company also announced that it is adding SPRAVATO(R), the first FDA-approved nasal spray, as a treatment option at three of its ketamine centers; the spray is intended to treat adults with treatment-resistant depression and depressive symptoms of major depressive disorder. In addition, the the company’s Delic Labs received Health Canada 56 exemptions to perform research and development work for several substances, including MDMA,…

Continue Reading

WednesdayMar 30, 2022 2:39 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Poised to Increase Overall Value on the Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, recently deployed additional European routing nodes. “The company’s available European routing nodes include Italy, Sweden, England, Ireland, France, and Germany. Europe contains approximately 43% of all Lightning Network nodes – second to North America,” a recent article reads. Since the November 2021 launch of the first routing node, US-West, LQwD has seen 157 nodes interconnected with more than 158 transaction channels, routing over 10 Bitcoin through these channels. “LQwD’s launch of these additional nodes firmly positions us to increase…

Continue Reading

WednesdayMar 30, 2022 2:27 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 24th Patent Sets the Stage for New Market Opportunities in Australia

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, celebrated the receipt of its 24th granted patent entitled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof.” Granted in Australia, this is the first patent awarded from the company’s 8th patent family. “The new patent expands on the company’s international IP rights to apply DehydraTECH(TM) technology to most forms of nicotine, namely sprays, gums, lozenges, pouches, capsules, tablets, and pills. It also covers multiple disparate forms of nicotine, including polymer resins of nicotine, freebase nicotine and other nicotine complexes,” reads a recent article. Prior to the…

Continue Reading

WednesdayMar 30, 2022 1:46 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Releases Spring 2022 Robot Roadshow Schedule

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced its spring 2022 Robot Roadshow schedule. Designed to be an engaging experiential event that allows Knightscope to connect with potential clients and showcase its proprietary crime-fighting robots, the Robot Roadshow will begin on April 12, 2022, and will tour 10 states, including Minnesota, Wisconsin, Illinois, Indiana and Ohio, with 35 scheduled stops. The roadshow will also be in Washington, D.C. during National Police Week. Creative marketing events such as the Robot Roadshow allow KSCP, a public safety innovator, to educate existing and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered